Cardiomyopathy Trial, Recruiting NCT06741995 Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06741995
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 years, of any gender
  • People who have been diagnosed with dilated cardiomyopathy
  • People (or their legal guardians) who are willing to participate voluntarily and sign a consent form after being fully informed about the study and its risks

Who may not be able to join:

  • People who have a serious infection at the time of enrollment that is not improving despite treatment
  • People who have active, uncontrolled bleeding at the time of enrollment
  • People who are pregnant or breastfeeding
  • People who have a serious illness in addition to their heart condition, such as cancer, where life expectancy is less than one year
  • People who have previously had a heart transplant or had a mechanical heart assist device implanted
  • People who may not be able to follow the study requirements and complete the full course of the trial
  • People who have other conditions — such as certain sensitivities, cognitive impairment, mental illness, or substance use issues — that the trial investigators believe could increase risk or affect study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-13886121012

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Registry
ClinicalTrials.gov
Start date
17 December 2024
Est. completion
17 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Composite Endpoint of All-Cause Death, Heart Transplantation, and Rehospitalization for Heart Failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov